UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2021-06, Vol.160 (7), p.2354-2366.e11

2021

Link zum Volltext

Verfügbarkeit prüfen

Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer

Acta oncologica, 2013-01, Vol.52 (1), p.82-90

2013

Link zum Volltext

Verfügbarkeit prüfen

Value of Epidermal Growth Factor Receptor, HER2, p53, and Steroid Receptors in Predicting the Efficacy of Tamoxifen in High-Risk Postmenopausal Breast Cancer Patients

Journal of clinical oncology, 2001-07, Vol.19 (14), p.3376-3384

2001

Link zum Volltext

Verfügbarkeit prüfen

Divergent estrogen receptor‐positive and ‐negative breast cancer trends and etiologic heterogeneity in Denmark

International journal of cancer, 2013-11, Vol.133 (9), p.2201-2206

2013

Link zum Volltext

Verfügbarkeit prüfen

Population-Based Study of Peritumoral Lymphovascular Invasion and Outcome Among Patients With Operable Breast Cancer

JNCI : Journal of the National Cancer Institute, 2009-05, Vol.101 (10), p.729-735

2009

Link zum Volltext

Verfügbarkeit prüfen

Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes

Acta oncologica, , Vol.43 (1), p.35-42

Link zum Volltext

Verfügbarkeit prüfen

Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancer

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2014-09, Vol.122 (9), p.750-754

2014

Link zum Volltext

Verfügbarkeit prüfen

Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark

JNCI : Journal of the National Cancer Institute, 2011-09, Vol.103 (18), p.1363-1372

2011

Link zum Volltext

Verfügbarkeit prüfen

Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer

Breast cancer research and treatment, 2011-06, Vol.127 (2), p.345-355

2011

Link zum Volltext

Verfügbarkeit prüfen

A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis

Acta oncologica, 2017-09, Vol.56 (9), p.1161-1167

2017

Link zum Volltext

Verfügbarkeit prüfen

Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients ( n = 647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study

European journal of cancer (1990), 2009-09, Vol.45 (14), p.2528-2536

2009

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy

Acta oncologica, 2012-07, Vol.51 (6), p.781-789

2012

Link zum Volltext

Verfügbarkeit prüfen

Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy

Breast (Edinburgh), 2012-10, Vol.21 (5), p.662-668

2012

Link zum Volltext

Verfügbarkeit prüfen

An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer

Acta oncologica, 2009, Vol.48 (4), p.522-531

2009

Link zum Volltext

Verfügbarkeit prüfen

The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors

Pharmacogenetics (London), 2002-08, Vol.12 (6), p.473-478

2002

Link zum Volltext

Verfügbarkeit prüfen

Abnormal routine blood tests as predictors of mortality in acutely admitted patients

Clinical biochemistry, 2020-03, Vol.77, p.14-19

2020

Link zum Volltext

Verfügbarkeit prüfen

Hydroxyethyl Starch Reduces Coagulation Competence and Increases Blood Loss During Major Surgery: Results From a Randomized Controlled Trial

Annals of surgery, 2014-02, Vol.259 (2), p.249-254

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of intravenous fluid restriction on postoperative complications: Comparison of two perioperative fluid regimens a randomized assessor-blinded multicenter trial

Annals of surgery, 2003-11, Vol.238 (5), p.641-648

2003

Link zum Volltext

Verfügbarkeit prüfen

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial

The Lancet (British edition), 1999-05, Vol.353 (9165), p.1641-1648

1999

Link zum Volltext

Verfügbarkeit prüfen

Study design, participation and characteristics of the Danish General Suburban Population Study

Danish medical journal, 2013-09, Vol.60 (9), p.A4693

2013

Link zum Volltext

Verfügbarkeit prüfen

CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial

Breast cancer research and treatment, 2015-06, Vol.151 (2), p.373-384

2015

Link zum Volltext

Verfügbarkeit prüfen

Coagulation competence for predicting perioperative hemorrhage in patients treated with lactated Ringer's vs. Dextran--a randomized controlled trial

BMC anesthesiology, 2015-12, Vol.15 (1), p.178-178, Article 178

2015

Link zum Volltext

Verfügbarkeit prüfen

Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes

BMJ (Online), 1996-04, Vol.312 (7035), p.871

International edition, 1996

Link zum Volltext

Verfügbarkeit prüfen

The Nottingham prognostic index applied to 9,149 patients from the studies of the danish breast cancer cooperative group (DBCG)

Breast cancer research and treatment, 1994, Vol.32 (3), p.281-290

1994

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic interaction studies of atosiban with labetalol or betamethasone in healthy female volunteers

BJOG : an international journal of obstetrics and gynaecology, 2005-11, Vol.112 (11), p.1492-1499

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(40)
Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Female
(36)
Aged
(30)
Adult
(26)
Biological And Medical Sciences
(20)
Medical Sciences
(19)
Oncology
(18)
Breast Neoplasms - Pathology
(14)
Male
(14)
Prognosis
(14)
Aged, 80 And Over
(10)
Breast Cancer
(10)
Breast Neoplasms - Drug Therapy
(9)
Follow-Up Studies
(8)
Treatment Outcome
(8)
Antineoplastic Agents, Hormonal - Therapeutic Use
(7)
Breast Neoplasms - Metabolism
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease

Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer

Value of Epidermal Growth Factor Receptor, HER2, p53, and Steroid Receptors in Predicting the Efficacy of Tamoxifen in High-Risk Postmenopausal Breast Cancer Patients

Divergent estrogen receptor‐positive and ‐negative breast cancer trends and etiologic heterogeneity in Denmark

Population-Based Study of Peritumoral Lymphovascular Invasion and Outcome Among Patients With Operable Breast Cancer

Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes

Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancer

Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark

Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer

A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis

Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients ( n = 647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study

Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy

Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy

An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer

The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors

Abnormal routine blood tests as predictors of mortality in acutely admitted patients

Hydroxyethyl Starch Reduces Coagulation Competence and Increases Blood Loss During Major Surgery: Results From a Randomized Controlled Trial

Effects of intravenous fluid restriction on postoperative complications: Comparison of two perioperative fluid regimens a randomized assessor-blinded multicenter trial

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial

Study design, participation and characteristics of the Danish General Suburban Population Study

CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial

Coagulation competence for predicting perioperative hemorrhage in patients treated with lactated Ringer's vs. Dextran--a randomized controlled trial

Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes

The Nottingham prognostic index applied to 9,149 patients from the studies of the danish breast cancer cooperative group (DBCG)

Pharmacokinetic interaction studies of atosiban with labetalol or betamethasone in healthy female volunteers

Aktive Filter

Suchergebnisse filtern